Read more
In Prescription for the People, Fran Quigley diagnoses our inability to get medicines to the people who need them and then prescribes the cure. He delivers a clear and convincing argument for a complete shift in the global and U.S. approach to developing and providing essential medicines--and a primer on how to make that change happen. Globally...
List of contents
Acknowledgments
Introduction
Part I
1. People Everywhere Are Struggling to Get the Medicines They Need
2. The United States Has a Drug Problem
3. Millions of People Are Dying Needlessly
4. Cancer Patients Face Particularly Deadly Barriers to Medicines
5. The Current Medicine System Neglects Many Major Diseases
Part II
6. Corporate Research and Development Investments Are Exaggerated
7. The Current System Wastes Billions on Drug Marketing
8. The Current System Compromises Physician Integrity and Leads to Unethical Corporate Behavior
9. Medicines Are Priced at Whatever the Market Will Bear
10. Pharmaceutical Corporations Reap History-Making Pro ts
Part III
11. The For-Profit Medicine Arguments Are Patently False
12. Medicine Patents Are Extended Too Far and Too Wide
13. Patent Protectionism Stunts the Development of New Medicines
14. Governments, Not Private Corporations, Drive Medicine Innovation
15. Taxpayers and Patients Pay Twice for Patented Medicines
Part IV
16. Medicines Are a Public Good
17. Medicine Patents Are Arti cial, Recent, and Government-Created
18. The United States and Big Pharma Play the Bully in Extending Patents
19. Pharma-Pushed Trade Agreements Steal the Power of Democratically Elected Governments
Part V
20. Current Law Provides Opportunities for Affordable Generic Medicines
21. There Is a Better Way to Develop Medicines
22. Human Rights Law Demands Access to Essential Medicines
Conclusion
Notes
Index
About the author
Fran Quigley
Summary
In Prescription for the People, Fran Quigley diagnoses our inability to get medicines to the people who need them and then prescribes the cure. He delivers a clear and convincing argument for a complete shift in the global and U.S. approach to developing and providing essential medicines—and a primer on how to make that change happen. Globally...
